BNP Paribas Financial Markets’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-502
| Closed | -$3.23K | – | 3981 |
|
|
2022
Q3 | $3.23K | Sell |
502
-2,959
| -85% | -$19.1K | ﹤0.01% | 3579 |
|
|
2022
Q2 | $33.3K | Buy |
3,461
+2,921
| +541% | +$28.1K | ﹤0.01% | 3004 |
|
|
2022
Q1 | $6.43K | Sell |
540
-735
| -58% | -$8.75K | ﹤0.01% | 3267 |
|
|
2021
Q4 | $41.6K | Buy |
1,275
+205
| +19% | +$6.69K | ﹤0.01% | 3126 |
|
|
2021
Q3 | $47.8K | Buy |
1,070
+855
| +398% | +$38.2K | ﹤0.01% | 2932 |
|
|
2021
Q2 | $11.7K | Sell |
215
-401
| -65% | -$21.8K | ﹤0.01% | 3087 |
|
|
2021
Q1 | $46K | Sell |
616
-290
| -32% | -$21.7K | ﹤0.01% | 3065 |
|
|
2020
Q4 | $98.3K | Sell |
906
-111
| -11% | -$12K | ﹤0.01% | 2576 |
|
|
2020
Q3 | $89.9K | Buy |
1,017
+704
| +225% | +$62.3K | ﹤0.01% | 2561 |
|
|
2020
Q2 | $33.3K | Sell |
313
-756
| -71% | -$80.5K | ﹤0.01% | 2572 |
|
|
2020
Q1 | $63.4K | Buy |
1,069
+668
| +167% | +$39.6K | ﹤0.01% | 2825 |
|
|
2019
Q4 | $27.7K | Sell |
401
-48
| -11% | -$3.32K | ﹤0.01% | 3239 |
|
|
2019
Q3 | $46.6K | Buy |
449
+169
| +60% | +$17.5K | ﹤0.01% | 2882 |
|
|
2019
Q2 | $25.9K | Sell |
280
-246
| -47% | -$22.8K | ﹤0.01% | 3178 |
|
|
2019
Q1 | $48.1K | Buy |
+526
| New | +$48.1K | ﹤0.01% | 2928 |
|
|
2018
Q4 | – | Sell |
-73
| Closed | -$8.66K | – | 3729 |
|
|
2018
Q3 | $8.66K | Hold |
73
| – | – | ﹤0.01% | 3138 |
|
|
2018
Q2 | $7.42K | Sell |
73
-223
| -75% | -$22.7K | ﹤0.01% | 3269 |
|
|
2018
Q1 | $38.5K | Buy |
296
+30
| +11% | +$3.9K | ﹤0.01% | 3100 |
|
|
2017
Q4 | $25.9K | Buy |
266
+134
| +102% | +$13K | ﹤0.01% | 3242 |
|
|
2017
Q3 | $19.4K | Sell |
132
-2
| -1% | -$294 | ﹤0.01% | 3086 |
|
|
2017
Q2 | $21.5K | Buy |
134
+124
| +1,240% | +$19.9K | ﹤0.01% | 3085 |
|
|
2017
Q1 | $1.59K | Sell |
10
-2
| -17% | -$319 | ﹤0.01% | 3028 |
|
|
2016
Q4 | $1.46K | Sell |
12
-5
| -29% | -$608 | ﹤0.01% | 3327 |
|
|
2016
Q3 | $2.3K | Buy |
+17
| New | +$2.3K | ﹤0.01% | 3451 |
|